Bicara Therapeutics appoints new CEO as current chief prepares to step down; former J&J executive joins Madrigal board
Bicara Therapeutics announced leadership changes, with President and COO Ryan Cohlhepp set to become CEO on January 1, replacing the departing chief. Additionally, John Reed, formerly of Johnson & Johnson, has joined the board of Madrigal Pharmaceuticals. The moves signal strategic shifts at both companies in the biotech sector.
Related stories
Replimune Appoints New Commercial Chief; Neumora Shakes Up Executive Ranks · Drug development
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Bicara shakes up leadership ahead of CEO departure; J&J's John Reed joins Madrigal's board.” Browse more stories.